Advance in the pharmacological and comorbidities management of heart failure with preserved ejection fraction: evidence from clinical trials
W Meifang, W Ying, C Wen, X Kaizu, S Meiyan… - Heart Failure …, 2024 - Springer
The prevalence of heart failure with preserved ejection fraction (HFpEF) accounts for
approximately 50% of the total heart failure population, and with the aging of the population …
approximately 50% of the total heart failure population, and with the aging of the population …